0 XP   0   0   0

Dr Habeebullah Life Sciences Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Dr Habeebullah Life Sciences Ltd?

I guess you are interested in Dr Habeebullah Life Sciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Dr Habeebullah Life Sciences Ltd

Let's start. I'm going to help you getting a better view of Dr Habeebullah Life Sciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Dr Habeebullah Life Sciences Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Dr Habeebullah Life Sciences Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Dr Habeebullah Life Sciences Ltd. The closing price on 2023-02-08 was INR27.55 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Dr Habeebullah Life Sciences Ltd Daily Candlestick Chart
Dr Habeebullah Life Sciences Ltd Daily Candlestick Chart
Summary









1. Valuation of Dr Habeebullah Life Sciences Ltd




Current price per share

INR27.55

2. Growth of Dr Habeebullah Life Sciences Ltd




Is Dr Habeebullah Life Sciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.6m$1.8m-$232.9k-14.6%

How much money is Dr Habeebullah Life Sciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money$181.3k-$93.9k$275.2k151.8%
Net Profit Margin6,673.1%-5,987.1%--

How much money comes from the company's main activities?

3. Financial Health of Dr Habeebullah Life Sciences Ltd




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Dr Habeebullah Life Sciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Dr Habeebullah Life Sciences Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Dr Habeebullah Life Sciences Ltd to the  industry mean.
  • A Net Profit Margin of 6,673.1% means that ₹66.73 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 6,673.1%. The company is making a huge profit. +2
  • The TTM is 6,673.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ6,673.1%TTM6,673.1%0.0%
TTM6,673.1%YOY-5,987.1%+12,660.2%
TTM6,673.1%5Y109.2%+6,563.9%
5Y109.2%10Y109.2%0.0%
1.1.2. Return on Assets

Shows how efficient Dr Habeebullah Life Sciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dr Habeebullah Life Sciences Ltd to the  industry mean.
  • 8.7% Return on Assets means that Dr Habeebullah Life Sciences Ltd generated ₹0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 8.7%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 8.7%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ8.7%TTM8.7%0.0%
TTM8.7%YOY-2.7%+11.5%
TTM8.7%5Y-2.4%+11.1%
5Y-2.4%10Y-2.4%0.0%
1.1.3. Return on Equity

Shows how efficient Dr Habeebullah Life Sciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dr Habeebullah Life Sciences Ltd to the  industry mean.
  • 11.3% Return on Equity means Dr Habeebullah Life Sciences Ltd generated ₹0.11 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 11.3%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 11.3%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ11.3%TTM11.3%0.0%
TTM11.3%YOY-7.0%+18.3%
TTM11.3%5Y-7.7%+19.0%
5Y-7.7%10Y-7.7%0.0%

1.2. Operating Efficiency of Dr Habeebullah Life Sciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dr Habeebullah Life Sciences Ltd is operating .

  • Measures how much profit Dr Habeebullah Life Sciences Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dr Habeebullah Life Sciences Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-69.1%+69.1%
5Y-69.1%10Y-69.1%0.0%
1.2.2. Operating Ratio

Measures how efficient Dr Habeebullah Life Sciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 25.71 means that the operating costs are ₹25.71 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 25.711. The company is inefficient in keeping operating costs low. -1
  • The TTM is 25.711. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ25.711TTM25.7110.000
TTM25.711YOY73.643-47.932
TTM25.7115Y26.094-0.383
5Y26.09410Y26.0940.000

1.3. Liquidity of Dr Habeebullah Life Sciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dr Habeebullah Life Sciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.84 means the company has ₹1.84 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 1.842. The company is able to pay all its short-term debts. +1
  • The TTM is 1.842. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.842TTM1.8420.000
TTM1.842YOY0.495+1.346
TTM1.8425Y0.865+0.977
5Y0.86510Y0.8650.000
1.3.2. Quick Ratio

Measures if Dr Habeebullah Life Sciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Dr Habeebullah Life Sciences Ltd to the  industry mean.
  • A Quick Ratio of 0.55 means the company can pay off ₹0.55 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 0.555. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.555. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.555TTM0.5550.000
TTM0.555YOY0.187+0.367
TTM0.5555Y0.329+0.225
5Y0.32910Y0.3290.000

1.4. Solvency of Dr Habeebullah Life Sciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dr Habeebullah Life Sciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Dr Habeebullah Life Sciences Ltd to industry mean.
  • A Debt to Asset Ratio of 0.23 means that Dr Habeebullah Life Sciences Ltd assets are financed with 22.8% credit (debt) and the remaining percentage (100% - 22.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 0.228. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.228. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.228TTM0.2280.000
TTM0.228YOY0.471-0.243
TTM0.2285Y0.380-0.152
5Y0.38010Y0.3800.000
1.4.2. Debt to Equity Ratio

Measures if Dr Habeebullah Life Sciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Dr Habeebullah Life Sciences Ltd to the  industry mean.
  • A Debt to Equity ratio of 29.5% means that company has ₹0.29 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 0.295. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.295. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.295TTM0.2950.000
TTM0.295YOY1.210-0.915
TTM0.2955Y0.844-0.549
5Y0.84410Y0.8440.000

2. Market Valuation of Dr Habeebullah Life Sciences Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Dr Habeebullah Life Sciences Ltd generates.

  • Above 15 is considered overpriced but always compare Dr Habeebullah Life Sciences Ltd to the  industry mean.
  • A PE ratio of 28.17 means the investor is paying ₹28.17 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The EOD is 27.228. Very good. +2
  • The MRQ is 28.167. Very good. +2
  • The TTM is 28.167. Very good. +2
Trends
Current periodCompared to+/- 
EOD27.228MRQ28.167-0.939
MRQ28.167TTM28.1670.000
TTM28.167YOY-83.227+111.394
TTM28.1675Y-18.562+46.729
5Y-18.56210Y-18.5620.000
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Dr Habeebullah Life Sciences Ltd.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The MRQ is 7.168. Seems overpriced? -1
  • The TTM is 7.168. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ7.168TTM7.1680.000
TTM7.168YOY-51.756+58.925
TTM7.1685Y-22.294+29.462
5Y-22.29410Y-22.2940.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Dr Habeebullah Life Sciences Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 3.19 means the investor is paying ₹3.19 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Dr Habeebullah Life Sciences Ltd:

  • The EOD is 3.084. Neutral. Compare to industry.
  • The MRQ is 3.191. Neutral. Compare to industry.
  • The TTM is 3.191. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD3.084MRQ3.191-0.106
MRQ3.191TTM3.1910.000
TTM3.191YOY4.266-1.075
TTM3.1915Y2.523+0.668
5Y2.52310Y2.5230.000
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Dr Habeebullah Life Sciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.300-1.3000%-0.429-67%2.233-158%2.233-158%
Book Value Growth--0.8730.8730%0.960-9%0.935-7%0.935-7%
Book Value Per Share--8.9328.9320%10.232-13%10.399-14%10.399-14%
Book Value Per Share Growth--0.8730.8730%0.960-9%0.913-4%0.913-4%
Current Ratio--1.8421.8420%0.495+272%0.865+113%0.865+113%
Debt To Asset Ratio--0.2280.2280%0.471-52%0.380-40%0.380-40%
Debt To Equity Ratio--0.2950.2950%1.210-76%0.844-65%0.844-65%
Dividend Per Share----0%-0%-0%-0%
Eps--1.0121.0120%-0.524+152%-0.617+161%-0.617+161%
Eps Growth--3.9293.9290%1.608+144%2.769+42%2.769+42%
Free Cash Flow Per Share---0.267-0.2670%-0.558+109%-1.387+420%-1.387+420%
Free Cash Flow Per Share Growth--1.5221.5220%1.617-6%1.564-3%1.564-3%
Free Cash Flow To Equity Per Share---0.267-0.2670%-0.558+109%-0.629+136%-0.629+136%
Free Cash Flow To Equity Per Share Growth--1.5221.5220%1.617-6%-0.373+124%-0.373+124%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--66.73166.7310%-59.871+190%1.092+6010%1.092+6010%
Operating Margin----0%-0%-0.6910%-0.6910%
Operating Ratio--25.71125.7110%73.643-65%26.094-1%26.094-1%
Pb Ratio3.084-3%3.1913.1910%4.266-25%2.523+26%2.523+26%
Pe Ratio27.228-3%28.16728.1670%-83.227+395%-18.562+166%-18.562+166%
Peg Ratio--7.1687.1680%-51.756+822%-22.294+411%-22.294+411%
Price Per Share27.550-3%28.50028.5000%43.650-35%25.788+11%25.788+11%
Price To Total Gains Ratio-21.188+3%-21.918-21.9180%-101.664+364%-40.316+84%-40.316+84%
Profit Growth--3.9293.9290%1.608+144%2.216+77%2.216+77%
Quick Ratio--0.5550.5550%0.187+196%0.329+68%0.329+68%
Return On Assets--0.0870.0870%-0.027+131%-0.024+127%-0.024+127%
Return On Equity--0.1130.1130%-0.070+161%-0.077+168%-0.077+168%
Revenue Growth--1.7311.7310%0.009+19005%0.817+112%0.817+112%
Total Gains Per Share---1.300-1.3000%-0.429-67%2.233-158%2.233-158%
Total Gains Per Share Growth---1.028-1.0280%1.612-164%0.163-730%0.163-730%
Usd Book Value--1600494.3821600494.3820%1833486.404-13%1827715.766-12%1827715.766-12%
Usd Book Value Change Per Share---0.016-0.0160%-0.005-67%0.027-158%0.027-158%
Usd Book Value Per Share--0.1080.1080%0.124-13%0.126-14%0.126-14%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0120.0120%-0.006+152%-0.007+161%-0.007+161%
Usd Free Cash Flow---47796.246-47796.2460%-100049.189+109%-238709.962+399%-238709.962+399%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.007+109%-0.017+420%-0.017+420%
Usd Free Cash Flow To Equity Per Share---0.003-0.0030%-0.007+109%-0.008+136%-0.008+136%
Usd Price Per Share0.333-3%0.3450.3450%0.528-35%0.312+11%0.312+11%
Usd Profit--181305.202181305.2020%-93977.348+152%-105601.900+158%-105601.900+158%
Usd Revenue--2716.9462716.9460%1569.660+73%105323.319-97%105323.319-97%
Usd Total Gains Per Share---0.016-0.0160%-0.005-67%0.027-158%0.027-158%
 EOD+4 -1MRQTTM+0 -0YOY+23 -155Y+22 -1610Y+22 -16

3.2. Fundamental Score

Let's check the fundamental score of Dr Habeebullah Life Sciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1527.228
Price to Book Ratio (EOD)Between0-13.084
Net Profit Margin (MRQ)Greater than066.731
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.555
Current Ratio (MRQ)Greater than11.842
Debt to Asset Ratio (MRQ)Less than10.228
Debt to Equity Ratio (MRQ)Less than10.295
Return on Equity (MRQ)Greater than0.150.113
Return on Assets (MRQ)Greater than0.050.087
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Dr Habeebullah Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose26.650
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets171,286
Total Liabilities39,014
Total Stockholder Equity132,272
 As reported
Total Liabilities 39,014
Total Stockholder Equity+ 132,272
Total Assets = 171,286

Assets

Total Assets171,286
Total Current Assets70,551
Long-term Assets70,551
Total Current Assets
Cash And Cash Equivalents 93
Net Receivables 21,245
Total Current Assets  (as reported)70,551
Total Current Assets  (calculated)21,339
+/- 49,212
Long-term Assets
Intangible Assets 32,595
Long-term Assets  (as reported)100,736
Long-term Assets  (calculated)32,595
+/- 68,140

Liabilities & Shareholders' Equity

Total Current Liabilities38,306
Long-term Liabilities708
Total Stockholder Equity132,272
Total Current Liabilities
Short Long Term Debt 27,407
Accounts payable 1,215
Other Current Liabilities 9
Total Current Liabilities  (as reported)38,306
Total Current Liabilities  (calculated)28,632
+/- 9,674
Long-term Liabilities
Long-term Liabilities  (as reported)708
Long-term Liabilities  (calculated)0
+/- 708
Total Stockholder Equity
Total Stockholder Equity (as reported)132,272
Total Stockholder Equity (calculated)0
+/- 132,272
Other
Capital Stock148,087
Common Stock Shares Outstanding 14,809
Net Debt 27,314
Net Invested Capital 159,679
Net Working Capital 32,245



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
262,232
282,122
286,501
171,286
171,286286,501282,122262,23200
   > Total Current Assets 
33,235
40,839
57,737
65,765
66,631
70,551
70,55166,63165,76557,73740,83933,235
       Cash And Cash Equivalents 
0
0
230
294
132
93
9313229423000
       Short-term Investments 
0
0
0
0
3,777
0
03,7770000
       Net Receivables 
32,745
36,134
31,710
31,151
21,426
21,245
21,24521,42631,15131,71036,13432,745
       Inventory 
13
952
1,592
1,311
1,292
0
01,2921,3111,59295213
       Other Current Assets 
223
304
24,205
30,599
30,604
0
030,60430,59924,205304223
   > Long-term Assets 
0
0
204,496
216,357
219,870
100,736
100,736219,870216,357204,49600
       Property Plant Equipment 
4,632
3,618
2,597
1,319
0
0
001,3192,5973,6184,632
       Intangible Assets 
0
0
177,670
189,926
193,978
32,595
32,595193,978189,926177,67000
> Total Liabilities 
0
0
99,715
124,236
134,973
39,014
39,014134,973124,23699,71500
   > Total Current Liabilities 
71,994
73,444
98,458
122,786
134,516
38,306
38,306134,516122,78698,45873,44471,994
       Short Long Term Debt 
0
0
79,180
85,840
93,946
27,407
27,40793,94685,84079,18000
       Accounts payable 
433
621
2,399
3,050
2,872
1,215
1,2152,8723,0502,399621433
       Other Current Liabilities 
0
0
3,466
33,653
9,271
9
99,27133,6533,46600
   > Long-term Liabilities 
0
0
1,257
1,450
456
708
7084561,4501,25700
> Total Stockholder Equity
0
0
122,017
117,831
111,507
132,272
132,272111,507117,831122,01700
   Retained Earnings -62,972-83,913-76,180-56,745-34,435-24,078
   Accumulated Other Comprehensive Income 000000
   Capital Surplus 000000
   Treasury Stock000000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2022-03-31)

Gross Profit (+$)
totalRevenue225
Cost of Revenue-1,508
Gross Profit-1,284-1,284
 
Operating Income (+$)
Gross Profit-1,284
Operating Expense-4,265
Operating Income-4,041-5,549
 
Operating Expense (+$)
Research Development-
Selling General Administrative210
Selling And Marketing Expenses-
Operating Expense4,265210
 
Net Interest Income (+$)
Interest Income1,646
Interest Expense--
Net Interest Income1,6081,646
 
Pretax Income (+$)
Operating Income-4,041
Net Interest Income1,608
Other Non-Operating Income Expenses-
Income Before Tax (EBT)14,984-4,041
EBIT - interestExpense = 0
14,984
14,984
Interest Expense-
Earnings Before Interest and Taxes (ebit)-14,984
Earnings Before Interest and Taxes (ebitda)-3,987
 
After tax Income (+$)
Income Before Tax14,984
Tax Provision-0
Net Income From Continuing Ops14,98414,984
Net Income14,984
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--1,608
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
TARMAT.NSE
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TARMAT.NSE.

TARMAT.NSE Daily Candlestick Chart
SYMPHONY.NSE
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SYMPHONY.NSE.

SYMPHONY.NSE Daily Candlestick Chart
SYMPHONY.BSE
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SYMPHONY.BSE.

SYMPHONY.BSE Daily Candlestick Chart
SWASTIVI.BSE
1 minute ago

I found you a Golden Cross on the daily chart of SWASTIVI.BSE.

SWASTIVI.BSE Daily Candlestick Chart
SVCIND.BSE
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SVCIND.BSE.

SVCIND.BSE Daily Candlestick Chart
SUUMAYA.BSE
1 minute ago

I found you a Three White Soldiers Candle Pattern on the daily chart of SUUMAYA.BSE.

SUUMAYA.BSE Daily Candlestick Chart
SUMIT.NSE
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SUMIT.NSE.

SUMIT.NSE Daily Candlestick Chart
SPCENET.NSE
7 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPCENET.NSE.

SPCENET.NSE Daily Candlestick Chart
SMFIL.BSE
8 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SMFIL.BSE.

SMFIL.BSE Daily Candlestick Chart
SKMEGGPROD.NSE
9 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SKMEGGPROD.NSE.

SKMEGGPROD.NSE Daily Candlestick Chart
SIPTL.BSE
10 minutes ago

I found you a Death Cross on the daily chart of SIPTL.BSE.

SIPTL.BSE Daily Candlestick Chart
SIL.NSE
11 minutes ago

I found you a Evening Star Candle Pattern on the daily chart of SIL.NSE.

SIL.NSE Daily Candlestick Chart
SHRGLTR.BSE
11 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of SHRGLTR.BSE.

SHRGLTR.BSE Daily Candlestick Chart
SHRADHA.NSE
11 minutes ago

I found you a MACD Bullish Reversal Divergence on the daily chart of SHRADHA.NSE.

SHRADHA.NSE Daily Candlestick Chart
SHIVA.BSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIVA.BSE.

SHIVA.BSE Daily Candlestick Chart
SHARIKA.BSE
12 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SHARIKA.BSE.

SHARIKA.BSE Daily Candlestick Chart
SHARDA.BSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHARDA.BSE.

SHARDA.BSE Daily Candlestick Chart
SGIL.BSE
12 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of SGIL.BSE.

SGIL.BSE Daily Candlestick Chart
SIL.BSE
13 minutes ago

I found you a Evening Star Candle Pattern on the daily chart of SIL.BSE.

SIL.BSE Daily Candlestick Chart
MTSM.JK
14 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of MTSM.JK.

MTSM.JK Daily Candlestick Chart
FILM.JK
15 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of FILM.JK.

FILM.JK Daily Candlestick Chart
CMRY.JK
17 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CMRY.JK.

CMRY.JK Daily Candlestick Chart
CASH.JK
17 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of CASH.JK.

CASH.JK Daily Candlestick Chart